Who Paid My Doc
A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus
ClinicalTrials.gov NCT06097299
Research payments
$795,479
Through program year 2025, $795,479 in research payments was reported against A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus, across 479 payments, paid by Moderna TX, Inc..
- Paid by
- Moderna TX, Inc.
- ClinicalTrials.gov
- NCT06097299
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $795,479 | 479 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Jennifer Nayak Rochester, NY Named on 39 payments
- Kashif Ali Houston, TX Named on 37 payments
- JOHN Clinton Port Lavaca, TX Named on 26 payments
- Jeffrey Baker Idaho Falls, ID Named on 25 payments
- Kem Yenal Wynnewood, PA Named on 22 payments
- Richard Bennett Richmond, VA Named on 21 payments
- Jibran Atwi Lafayette, LA Named on 20 payments
- John SCOTT Richmond, VA Named on 18 payments
- Gamalier Mestre Orlando, FL Named on 17 payments
- Scott Striplin Covington, LA Named on 15 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.